{"disease":{"id":"bradykinin-mediated-angioedema","name":"bradykinin mediated angioedema"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07046806","title":"Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Institute for Asthma and Allergy","has_results":false},{"nct_id":"NCT07290855","title":"A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Nang Kuang Pharmaceutical Co., Ltd.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}